Tibet Weixinkang Medicine Co Ltd Tangible Net Worth Ratio
Tibet Weixinkang Medicine Co Ltd tangible net worth ratio. Tibet Weixinkang Medicine Co Ltd (603676) has a Tangible Net Worth Ratio of 96.9% as of June 2026. This metric is calculated by deducting intangible assets (CN¥47.61 Million) from net assets (CN¥1.54 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset growth rate of Tibet Weixinkang Medicine Co Ltd to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Tibet Weixinkang Medicine Co Ltd (2013–2025)
Tangible net worth ratio of Tibet Weixinkang Medicine Co Ltd from 2013 to 2025. This chart shows how Tibet Weixinkang Medicine Co Ltd's Tangible Net Worth Ratio has changed across 13 annual periods from 2013 to 2025. As of June 2026, the ratio stands at 96.9%, reflecting net assets of CN¥1.54 Billion with intangible assets of CN¥47.61 Million CNY. Check Tibet Weixinkang Medicine Co Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Tibet Weixinkang Medicine Co Ltd Tangible Net Worth Ratio by Year (2013–2025)
Tibet Weixinkang Medicine Co Ltd tangible net worth ratio by year from 2013 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Tibet Weixinkang Medicine Co Ltd from 2013 to 2025, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market cap of Tibet Weixinkang Medicine Co Ltd.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 97.5% | CN¥1.48 Billion | CN¥36.90 Million | CN¥1.87 Billion | ▼ -0.3 pp |
| 2024 | 97.8% | CN¥1.39 Billion | CN¥30.43 Million | CN¥1.85 Billion | ▲ +2.1 pp |
| 2023 | 95.7% | CN¥1.34 Billion | CN¥57.91 Million | CN¥1.78 Billion | ▲ +0.8 pp |
| 2022 | 94.9% | CN¥1.22 Billion | CN¥62.45 Million | CN¥1.66 Billion | ▲ +2.5 pp |
| 2021 | 92.4% | CN¥1.07 Billion | CN¥81.55 Million | CN¥1.50 Billion | ▼ -1.0 pp |
| 2020 | 93.4% | CN¥983.21 Million | CN¥65.04 Million | CN¥1.36 Billion | ▼ -1.4 pp |
| 2019 | 94.8% | CN¥930.05 Million | CN¥48.05 Million | CN¥1.30 Billion | ▼ -0.2 pp |
| 2018 | 95.1% | CN¥897.64 Million | CN¥44.16 Million | CN¥1.23 Billion | ▼ 0.0 pp |
| 2017 | 95.1% | CN¥858.04 Million | CN¥42.20 Million | CN¥1.02 Billion | ▲ +2.0 pp |
| 2016 | 93.1% | CN¥459.42 Million | CN¥31.91 Million | CN¥552.36 Million | ▼ -0.3 pp |
| 2015 | 93.4% | CN¥402.93 Million | CN¥26.63 Million | CN¥508.75 Million | ▼ -2.0 pp |
| 2014 | 95.3% | CN¥286.28 Million | CN¥13.34 Million | CN¥363.37 Million | ▼ -1.3 pp |
| 2013 | 96.6% | CN¥247.78 Million | CN¥8.36 Million | CN¥309.30 Million | — |